Added another 100k shares today thank you for the cheap shares ....

Added another 100k shares today thank you for the cheap shares . We are close to Phase 2 readout and this dirt cheap stock is a potential takeover candidate .

ANTISENSE THERAPEUTICS SUMMARY & VALUE DRIVERS
https://www.asx.com.au/asxpdf/20190625/pdf/44630r6yht8gkg.pdf

Advanced stage product pipeline –two compounds with positive Phase II clinical results published in high quality peer reviewed scientific journals

Highly regarded substantial shareholders –have increased their holdings

Phase II clinical trial in Duchenne Muscular Dystrophy (DMD) – ATL1102

−Trial is fully enrolled, results expected Q4 CY2019
−Phase IIb trial design and approval process to run in parallel, accelerating development of ATL1102
−Drug potentially complementary to other DMD programs e.g. SareptaTherapeutics
−Significantly ‘underserved market’ with comparable company benchmarks demonstrating substantial value creation potential

Establishing Early Access Program (EAP) for acromegaly – ATL1103

−Plan to provide ATL1103 to acromegaly patients under an EAP in Europe
−Potential for income generation & partnering to further develop the compound
-----

ANP: Why partnering with big biotech has its benefits
https://finfeed.com/small-caps/biotech/anp-why-partnering-big-biotech-has-its-benefits/